It has recently been shown that carriers of bi-allelic loss-of-function (LoF) variants in NTHL1 are predisposed to colorectal adenomatous polyposis and colorectal cancer1, and to a multi-tumor syndrome that includes a high incidence of breast cancer in female carriers2–5. The gene discussed is NTHL1; the disease is breast carcinoma.